General MD

This section is for doctors who are considering the selection of PRRT to treat one of their patients.

Considering PRRT for a Patient: What a physician should look for

Progressive, somatostatin receptor positive neuroendocrine tumor patients (non-resectable disease) with the following characteristics:

* A fundamental prerequisite is that high somatostatin receptor expression has been proven before PRRT by OctreoScan or (preferable) by Ga-68 DOTATOC PET/CT.

* Renal function and blood counts